U.S. Sterile Injectable Contract Manufacturing Market Size & Outlook
U.S. sterile injectable contract manufacturing market, 2018-2030 (US$M)
Related Markets
U.S. sterile injectable contract manufacturing market highlights
- The U.S. sterile injectable contract manufacturing market generated a revenue of USD 6,130.8 million in 2024 and is expected to reach USD 12,602.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.8% from 2025 to 2030.
- In terms of segment, large molecule was the largest revenue generating molecule type in 2024.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Sterile injectable contract manufacturing market data book summary
| Market revenue in 2024 | USD 6,130.8 million |
| Market revenue in 2030 | USD 12,602.9 million |
| Growth rate | 12.8% (CAGR from 2024 to 2030) |
| Largest segment | Large molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | Baxter International Inc, Catalent Inc, Recipharm, Fresenius SE & Co KGaA, Cipla Ltd DR, Vetter Pharma-Fertigung, Aenova Group, Unither Pharmaceuticals, Famar, Sorrento Therapeutics Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.3% of the global sterile injectable contract manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. sterile injectable contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 12,602.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sterile Injectable Contract Manufacturing Market Scope
Sterile Injectable Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. sterile injectable contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectable contract manufacturing market will help companies and investors design strategic landscapes.
Large molecule was the largest segment with a revenue share of 67.07% in 2024. Horizon Databook has segmented the U.S. sterile injectable contract manufacturing market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. sterile injectable contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. sterile injectable contract manufacturing market databook
-
Our clientele includes a mix of sterile injectable contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. sterile injectable contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. sterile injectable contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. sterile injectable contract manufacturing market size, by molecule type, 2018-2030 (US$M)
U.S. Sterile Injectable Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
